Risk Factors for Bone Microarchitecture Impairments in Older Men With Type 2 Diabetes—The MrOS Study

J Clin Endocrinol MetabPublished Cross-sectional study

Authors' conclusion

Older men with T2DM have smaller bone size compared to those without T2DM, which may contribute to diabetic skeletal fragility. Longer diabetes duration was associated with higher cortical porosity and insulin use with cortical bone deficits and lower failure load.

Study context

Population
Older men in the Osteoporotic Fractures in Men (MrOS) study with high-resolution peripheral quantitative computed tomography (HR-pQCT) scans1,794 scanned
Participants
1,777 men
Exposure
T2DM vs non-T2DM
  • T2DMn = 290
Outcome
HR-pQCT bone microarchitecture parameters by diabetes status
Methodological detailsmulticentre, linear regression adjusted for age, race, BMI, limb length, clinic site and oral corticosteroid use
  • Multicentre
  • Linear regression adjusted for age, race, BMI, limb length, clinic site and oral corticosteroid use

Main finding

As reported in the abstract

HR-pQCT parameters, T2DM vs non-T2DM
  • Trabecular indices and cortical porosity were similar between T2DM and non-T2DM
  • T2DM vs non-T2DM: P = 0.028
  • T2DM vs non-T2DM: P = 0.025
  • T2DM vs non-T2DM: P = 0.009
  • T2DM vs non-T2DM: P = 0.023

Observational data: associations, not effects.

Further findings

Diabetes duration ≥10 vs <10 years (T2DM men; model incl. HbA1c, duration, insulin use)

Significantly associated with higher cortical porosity but higher trabecular thickness at the distal radius

Insulin use (T2DM men)

Significantly associated with lower cortical area and thickness at distal radius and diaphyseal tibia and lower failure load at all 3 scan sites

Incident nonvertebral fracture in T2DM

Lower cortical area, cortical thickness, total BMD, cortical BMD and failure load of the distal sites associated with increased risk

Original publication

Risk Factors for Bone Microarchitecture Impairments in Older Men With Type 2 Diabetes—The MrOS Study. J Clin Endocrinol Metab. Published 12 July 2024. doi:10.1210/clinem/dgae452

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.